Adjuvant Therapy for Breast Cancer

Adjuvant Therapy for Breast Cancer PDF Author: Monica Castiglione
Publisher: Springer Science & Business Media
ISBN: 0387751157
Category : Medical
Languages : en
Pages : 483

Get Book Here

Book Description
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.

Adjuvant Therapy for Breast Cancer

Adjuvant Therapy for Breast Cancer PDF Author: Monica Castiglione
Publisher: Springer Science & Business Media
ISBN: 0387751157
Category : Medical
Languages : en
Pages : 483

Get Book Here

Book Description
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.

Adjuvant Therapy of Cancer V

Adjuvant Therapy of Cancer V PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


Adjuvant Therapy of Cancer VIII

Adjuvant Therapy of Cancer VIII PDF Author: Sydney E. Salmon
Publisher: Lippincott Williams & Wilkins
ISBN: 9780397584437
Category : Medical
Languages : en
Pages : 330

Get Book Here

Book Description


Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II

Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II PDF Author: Gianni Bonadonna
Publisher: Springer Science & Business Media
ISBN: 3642813321
Category : Medical
Languages : en
Pages : 479

Get Book Here

Book Description
1978 Annual Plenary Meeting of the European Organization for Research on Treatment of Cancer, Paris, June 1978

Adjuvant Therapy of Breast Cancer V

Adjuvant Therapy of Breast Cancer V PDF Author: Hans-Jörg Senn
Publisher: Springer Science & Business Media
ISBN: 3642792782
Category : Medical
Languages : en
Pages : 337

Get Book Here

Book Description
We often hear physicians, health care professionals, poli ticians, and patient advocates that "nothing has happened in the treatment of breast cancer," since patients with breast cancer, the most frequent neoplastic condition in women in industrialized countries, are continuing to suffer relapse and succumb to this dreadful disease! This negativistic attitude does not seem to be justified, but, why is the transmission of clinical trial results into general practice, and with it progress, such a slow process? After many decades of frustrating stagnation of long-term survival expectations, in all stages of early, oper/lble breast cancer treated only by surgery and locoregional radio therapy, adjuvant systemic therapy (chemo- as well as endocrine treatments) clearly showed to significantly benefit in terms of disease-free and overall survival. This evolution has been extensively expounded on by the Worldwide Oxford Overview and the Expert Consensus Panel at the fourth International Conference 'on Adjuvant Therapy of Primary Breast Cancer in St. Gallen (Early Breast Cancer Trialists' Collaborative Group 1992; Glick et al. 1992). What has happened since then? During the past 3-5 years, several new concepts and treatment strategies have emerged and have been studied in various major breast cancer groups and treatment centers worldwide. Some of these can already be considered to assist in the primary treatment of operable breast cancer today, while others are . still undergoing clini,cal trials for better definition of their practical usefulness.

Adjuvant Therapy of Breast Cancer

Adjuvant Therapy of Breast Cancer PDF Author: I. Craig Henderson
Publisher: Springer
ISBN: 9781461365501
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
The results of randomized trials evaluating the use of early or adjuvant systemic treatment for patients with resectable breast cancer provide an eloquent rebuttal to those who would argue that we have made no progress in the treatment of cancer. Many of the tumors that we have been most successful in curing with chemotherapy and other newer forms of treatment are relatively uncommon. In contrast, breast cancer continues to be the single most common malignancy among women in the western world, is increasingly a cause of death throughout Asia and Third-World countries, and remains one of the most substantial causes of cancer mortality world wide. The use of mammography as a means of early detection has been shown to reduce breast cancer mortality by 25-35% among those popu lations in which it is utilized. The use of adjuvant systemic treatment in appropriate patients provides a similar (and additional) reduction in breast cancer mortality. Few subjects have been so systematically studied in the history of medicine, and it seems fair to conclude that the value to adjuvant systemic therapy in prolonging the lives of women with breast cancer is more firmly supported by empirical evidence than even the more conventional or primary treatments using various combinations ofsurgery and radiotherapy.

Surgical Management of Advanced Pelvic Cancer

Surgical Management of Advanced Pelvic Cancer PDF Author: Desmond C. Winter
Publisher: John Wiley & Sons
ISBN: 1119518407
Category : Medical
Languages : en
Pages : 324

Get Book Here

Book Description
An innovative guide to the practice of pelvic exenterative surgery for the management of advanced pelvic neoplasms Exenterative surgery plays an important role in the management of advanced pelvic cancer. However, while a large body of evidence regarding outcomes following pelvic exenteration now exists, practical strategies and management options remain unclear. Surgical Management of Advanced Pelvic Cancer addresses this problem by assembling world-leaders in the field to provide insights into the latest techniques and best practices. It includes detailed coverage of: Surgical anatomy Operative approaches and exenterative techniques Reconstruction options Current evidence on survival and quality of life outcomes Featuring essential information for those managing patients with advanced pelvic neoplasms, Surgical Management of Advanced Pelvic Cancer consolidates the latest data and practical advice in one indispensable guide.

Interdisciplinary Cancer Therapy

Interdisciplinary Cancer Therapy PDF Author: Everett V. Sugarbaker
Publisher:
ISBN: 9780815199038
Category : Cancer
Languages : en
Pages : 69

Get Book Here

Book Description


HER2-Positive Breast Cancer

HER2-Positive Breast Cancer PDF Author: Sara Hurvitz
Publisher: Elsevier Health Sciences
ISBN: 0323581234
Category : Medical
Languages : en
Pages : 264

Get Book Here

Book Description
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

Non-melanoma Skin Cancer of the Head and Neck

Non-melanoma Skin Cancer of the Head and Neck PDF Author: Faruque Riffat
Publisher: Springer
ISBN: 8132224973
Category : Medical
Languages : en
Pages : 214

Get Book Here

Book Description
Non-melanoma skin cancer is a global public health issue. With an ever-increasing, and ageing, world population coupled with increasing numbers of immunosuppressed individuals the number of patients continues to rise. The head and neck is overwhelmingly the most frequent location for the development of a non-melanoma skin cancer and as such challenges the clinician with its complex anatomy. The importance of maintaining the aesthetics of the face and the function of the anatomy cannot be overstated, yet ultimately it is always the aim of curing a patient with the minimum of morbidity that clinicians strive for. However, the spectrum of presentations and subsequent management varies widely, ranging from patients with the ubiquitous low-risk mid-face basal cell carcinoma to those diagnosed with relatively uncommon but potentially life-threatening high-risk squamous cell carcinomas (e.g. involving metastatic lymph nodes or with perineural invasion present) and Merkel cell carcinomas.